Krystal Biotech Inc. (KRYS)
Krystal Biotech Max Pain By Strike
KRYS trades at $150.42, 7.4% above the near-term max pain of $140 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($75-$240), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Krystal Biotech Max Pain By Expiry
Max pain for KRYS shows a downward trend from 240 to 75, indicating bearish sentiment or hedging activity. The 121% spread signals divergent expectations across timeframes. Most levels below 150.42 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 140 | -10.42 (-6.93%) |
| Oct 17, 2025 | 90 | -60.42 (-40.17%) |
| Nov 21, 2025 | 145 | -5.42 (-3.60%) |
| Dec 19, 2025 | 240 | 89.58 (59.55%) |
| Feb 20, 2026 | 130 | -20.42 (-13.58%) |
| Dec 18, 2026 | 75 | -75.42 (-50.14%) |